SFM
DICE

Sphera Funds Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Sphera Funds Management’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-150,000
Closed -$3.04M – 91
2022
Q3 		$3.04M Buy
+150,000
New +$2.73M 0.42% 51

Other funds holding DICE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Sphera Funds Management's DICE Position: Q4 2022 in Review

Sphera Funds Management sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q4 2022, closing a stake of 152,913 shares — an estimated $3.1M sold.

Sphera Funds Management first reported a position in DICE in Q3 2021 and held it in 2 quarters. The position peaked at $3.1M in Q3 2022. 109 funds tracked by Wall St. Rank hold DICE as of Q4 2022.

  • Sphera Funds Management reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Sphera Funds Management sold 152,913 DICE Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $3.1M.
  • Sphera Funds Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2021 and held it in 2 quarters.
  • Sphera Funds Management's DICE Therapeutics, Inc. Common Stock position peaked at $3.1M in Q3 2022.
  • 109 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Sphera Funds Management's 13F filing for Q4 2022, filed 14 Feb 2023.